Navigation Links
Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/2/2010

e treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C.  The Company has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements."  Such statements include, but are not limited to, references to Anadys' strategy, development programs, and ability to develop novel medicines for the treatment of hepatitis C.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.  For example, the results of preclinical and early clinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 or ANA773 will not have unforeseen safety issues, will have favorable results in ongoing or future clinical trials or will receive regulatory approval.  Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2008 and Anadys' Form 10-Q for the quarter ended September 30, 2009.  All forward-looking statements are qualified in their entirety by this cautionary statement.  Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statem
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
2. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
3. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
5. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
6. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
7. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
8. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
9. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
10. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
11. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... COPENHAGEN, Denmark , Sept. 3, 2015 ... ), a clinical stage biotechnology company that ... significant unmet medical needs, today announced plans ... , 2015 Wells Fargo Healthcare Conference in ... 1:55pm EDTEvent: , Bank of America Merrill ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Global Medical Devices Packaging Market - By Packaging ... 2014 - 2020" report to their offering. ... is driven directly by its end use industry, i.e., ... the packaging of these devices so as to be ...
(Date:9/3/2015)... , September 3, 2015 , ...   High need for translation ... quality of life   , ... Pain Federation EFIC ® , young scientists from across ... projects, focussing on novel ideas with potential for achieving major advances ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 2Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 3Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 4Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 5
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... workshops included in Patient Experience Conference 2016, to be held April 13-15 at ... or vendor hosted event bringing together the collective voices of healthcare leaders, staff, ...
(Date:9/3/2015)... ... September 03, 2015 , ... DriButts, a ... partnered with Slingshot® Product Development Group to manufacture a long-lasting reusable diaper for ... with DriButts plans to bring 600 DriButts Diapers to rural areas of Haiti ...
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief ... professional bull rider David Mason has signed an official endorsement deal with the company. ... of six and his first bull at 15. He is an Australian bull riding ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Florida Companies to Watch for 2015 by economic development group GrowFL and ... 50 companies in the state selected for this prestigious award, which recognizes growing ...
(Date:9/3/2015)... SAN FRANCISCO, CA (PRWEB) , ... September 03, ... ... is transforming the real estate investment landscape by connecting accredited and institutional investors ... mezzanine financing products designed to meet demand from both investors and ...
Breaking Medicine News(10 mins):Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3
... in mouse study may someday extend men,s lives, , ... has proven useful in treating late-stage prostate cancer, it ... that are resistant to such therapy. , Now, however, ... mechanism by which the secondary tumors gain their resistance ...
... ... ... ... ...
... Texas, U.S.A. (March 10, 2010) Sketched at a ... anatomical drawings of Leonardo da Vinci display his rare ... a new art catalog of the medieval drawings. ... biology at The University of Texas Health Science Center ...
... , ... ... ... ...
... and an existing drug might help, scientists say , ... they,ve learned new details about molecular mechanisms associated with ... new treatments for alcoholism. , The University of California, ... alcohol or sugar for nearly two months, followed by ...
... While physicians strive to set realistic expectations for patients ... reveals that doctor and patient expectations are sometimes not ... researchers at the American Academy of Orthopedic Surgeons held ... steps need to be taken to bridge the expectation ...
Cached Medicine News:Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference 2Health News:Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference 3Health News:Leonardo's anatomical sketches fascinate modern-day anatomist 2Health News:DC Dermatologist Dr. Susan T. Elliott Selected 'Best Doctor' by Washingtonian Magazine 2Health News:DC Dermatologist Dr. Susan T. Elliott Selected 'Best Doctor' by Washingtonian Magazine 3Health News:Alcoholics' Relapses Better Understood 2Health News:Patient and doctor expectations from joint replacement surgeries not always aligned 2Health News:Patient and doctor expectations from joint replacement surgeries not always aligned 3Health News:Patient and doctor expectations from joint replacement surgeries not always aligned 4
... centrifuges -- the world's most popular Microhematocrit ... one reliable, quiet, compact unit. It is ... separate centrifuges!, For your microcentrifuge needs, order ... you with the MicroMB centrifuge, microcentrifuge rotor ...
... spins up to 25,000 x g for quick and ... ease of use. The Model 5417 C is designed ... cold room and can accommodate a variety of microcentrifuge ... Spin up to 16,400 rpm; 25,000 x g ...
... The Model EXD explosion-proof laboratory floor model ... explosion-proof apparatus. EXD is suitable for use ... all divisions; "atmospheres containing gasoline, petroleum, naphtha, ... Adherence to these specifications is so strict ...
... Oven/Shaker rigidly controls the temperature and ... hybridization and washing steps. This facilitates ... nucleic acids and proteins immobilized on ... radioactive and nonradioactive labeling systems supplied ...
Medicine Products: